• Isabel Rauscher, Tobias Maurer, Michael Souvatzoglou, Ambros J Beer, Tibor Vag, Martina Wirtz, Gregor Weirich, Hans-Jürgen Wester, Jürgen E Gschwend, Markus Schwaiger, Margret Schottelius, and Matthias Eiber.
• From the Departments of *Nuclear Medicine and †Urology, Klinikum rechts der Isar, Technische Universität München, Munich; ‡Department of Nuclear Medicine, University Hospital Ulm, Ulm; §Pharmaceutical Radiochemistry, Technische Universität München, Garching; and ∥Department of Pathology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
• Clin Nucl Med. 2016 Sep 1; 41 (9): e397-402.

PurposeThe aim of this study was to evaluate the detection efficiency of In-PSMA-I&T SPECT/CT in comparison to hybrid Ga-PSMA HBED-CC PET in patients with early recurrent prostate cancer.MethodsTwenty-two patients (mean age, 68.2 ± 6.8 years; range, 52-76 years) with rising prostate-specific antigen (PSA; median, 1.03 ng/mL; range, 0.2-7.2ng/mL) and known positive lesions in hybrid Ga-PSMA HBED-CC PET scheduled for salvage surgery were included. Whole-body scintigraphy and SPECT/CT were performed 4 hours after application of 147.0 ± 24.8 MBq (range, 90-183 MBq) In-PSMA I&T. Images were evaluated for suspected lesions, and conspicuity of all lesions was rated using a 4-point-scale (0 = not seen, 1 = retrospectively seen in knowledge of Ga-PSMA HBED-CC PET, 2 = low signal, 3 = high signal). Tumor-to-background ratios were determined for SPECT and PET and compared. Tumor-to-background ratio of SPECT was correlated with lesion size as well as patients' Gleason score and PSA level.ResultsIn-PSMA I&T SPECT/CT detected 14 of 29 PET-positive lesions (48.3%) with no additional lesions identified with In-PSMA I&T SPECT/CT. There was a significant weak to moderate correlation of PSA level with tumor-to-background ratio of In-PSMA I&T SPECT/CT (correlation coefficient r = 0.6406; 95% confidence interval, 0.1667-0.8741; P = 0.0136). There was no significant difference (P > 0.05), but a weak trend toward a higher detectability in In-PSMA I&T SPECT/CT regarding lesion size and initial PSA level.ConclusionsIn a preselected collective of recurrent prostate cancer patients with low PSA values, In-PSMA I&T SPECT/CT showed lower detection rates than hybrid Ga-HBED-CC PSMA PET. However, In-PSMA I&T SPECT/CT showed a patient based detection rate of 59%, making it a potentially valuable imaging tool where PET is not available apart from its proven value as a PSMA-targeted probe for radioguided surgery.

22 keywords...

hide…